AllSight
Companies · JBIO · Pharmaceutical Preparations

Jade Biosciences, Inc. (JBIO)

Jade Biosciences, Inc. (JBIO) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Jade Biosciences, Inc. (JBIO) stock — financials & valuation

Key numbers for Jade Biosciences, Inc. (JBIO): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 45/100 — a percentile rank of Jade Biosciences, Inc.’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.

Market cap$893.5M
EV / EBITDA-5.0×
Return on equity-28.0%
ROIC-47.4%
Debt / equity0.0×
Dividend yield0.0%

Independent of the events above — derived from Jade Biosciences, Inc.’s own financial statements and shown as context, never as advice.

Sep 30, 2026Preclinical update
Jade Biosciences preclinical data sharpens JADE301 case ahead of Phase 1
Aug 10, 2026
Strong JADE101 progress and earlier JADE301 timing, but EPS missed expectations
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact